Viewing nowNewpex Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Korea United Pharm Co., Ltd.

MFDS item code 201208998 · Approved 2012.11.30 · Insurance code 644308440
Improvement of hyperlipidemia and familial hypercholesterolemia in children; prevention of cardiovascular diseases
This medication helps reduce the risk of myocardial infarction, stroke, the need for vascular interventions, angina, and hospitalization due to congestive heart failure in adults with multiple risk factors related to coronary artery heart disease and patients with type 2 diabetes. It is also effective in maintaining cardiovascular health by reducing total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides, and increasing HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. This drug is also used in patients with dyslipidemia not controlled by diet or patients with homozygous familial hypercholesterolemia. In addition, it aids in improving lipid levels to prevent atherosclerosis early in pediatric patients aged 10 to 17 who have heterozygous familial hypercholesterolemia. This medication is used for reducing the risk of cardiovascular disease and improving hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, considering treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults: The efficacy and safety in patients 70 years of age and older are similar to those in the general adult population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses higher than 20 mg of this medicine to pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may cause muscle-related symptoms, so if muscle pain or weakness worsens, or creatine kinase levels significantly increase, it should be discontinued immediately. It should not be used in individuals with an allergy to this drug, those with severe liver disease or active liver disease, individuals with muscle disorders, pregnant or nursing women, and children under 10 years old. Patients with a history of alcohol abuse or liver disease, those with impaired kidney function, patients with hypothyroidism, and the elderly should use this medication with caution and closely monitor for muscle-related symptoms. Regular liver function tests and muscle-related tests should be conducted during treatment, and if symptoms of hepatitis or severe muscle pain occur, medical consultation should be sought immediately. Caution is advised regarding drug interactions as the blood concentration of this medication may increase or decrease when taken with certain drugs, especially when combined with antibiotics, antifungals, some antivirals, cyclosporine, grapefruit juice, etc. Women of childbearing age should use adequate contraception while taking this drug and should not use it if pregnant or planning to become pregnant. Nursing mothers should not take this medication and special attention should be paid to monitoring adverse effects in children or the elderly when taking this drug. There is no specific antidote for overdose; treatment is based on symptoms, and it should be stored out of reach of children. Rarely, skin rashes or severe skin reactions may occur, so if abnormal symptoms arise, discontinue use immediately and inform healthcare professionals.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to ensure the medication's effectiveness is preserved safely over time.
White round film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Korea United Pharm Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.